Aims. To determine the time elapsed from when a patient 65 years old is diagnosed with type 2 diabetes mellitus (T2DM) and begins antidiabetic treatment until a change in treatment is required as well as the factors associated with the change. Methods.
Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacoepidemiología
- Autores: Jorge Enrique Machado-Alba, Manuel Enrique Machado-Duque, Andrés Gaviria-Mendoza
- Idiomas: Inglés
- Palabras clave: "Diabetes mellitus tipo 2 envejecida, Medicamentos antidiabéticos Metformina Análisis de supervivencia FarmacoepidemiologiaAged Diabetes mellitus, Type 2 Antidiabetic drugs Metformin Survival analysis Pharmacoepidemiology"
Machado-Alba JE, Machado-Duque ME, Gaviria-Mendoza A. Time to modification of antidiabetic therapy in patients over the age of 65 years with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020;162:108090. doi:10.1016/j.diabres.2020.108090 Enlace: https://pubmed.ncbi.nlm.nih.gov/32088311/
